27 May 2015

Cyclo-Progynova (Estradiol valerate / Norgestrel) - United Kingdom

ATC: G03FB
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
PROGESTOGENS AND ESTROGENS IN COMBINATION
PROGESTOGENS AND ESTROGENS, SEQUENTIAL PREPARATIONS
Cyclo-Progynova

Last Updated on 27 May 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Cyclo-Progynova Indication

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in perimenopausal and postmenopausal women.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

 

Cyclo-Progynova Generic Name

Estradiol valerate / Norgestrel

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - Cyclo-Progynova 2mg (external site)

Free Medical Education Resources

Cyclo-Progynova Marketing Information

Cyclo-Progynova Generic Name
Estradiol valerate / Norgestrel
Marketing Company
Meda Pharmaceuticals Ltd
Drug Type
POM
Date of Issue, Marketing Authority 01/12/2009

Related Drugs - Women's Health and Obs/Gyn

Back to top